Login to Your Account



Clinic Roundup


Wednesday, November 30, 2011
• Omthera Pharmaceuticals Inc., of Bedminster, N.J., completed enrollment in a pivotal, Phase III trial of Epanova, its triglyceride-lowering therapy. The trial, designated EVOLVE, is being carried out under a special protocol assessment with the FDA.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription